Aspen Aerogels (NYSE:ASPN) Shares Down 5.2% – Should You Sell?

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report)’s share price fell 5.2% during trading on Thursday . The stock traded as low as $6.98 and last traded at $6.97. 733,678 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 1,785,620 shares. The stock had previously closed at $7.35.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ASPN. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. B. Riley lowered their price objective on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Wednesday, February 19th. Barclays lowered their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 19th. TD Cowen upgraded Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Finally, Canaccord Genuity Group decreased their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $19.11.

View Our Latest Stock Report on ASPN

Aspen Aerogels Price Performance

The firm has a market capitalization of $578.93 million, a P/E ratio of 44.10 and a beta of 2.28. The firm has a 50 day moving average price of $9.61 and a 200-day moving average price of $15.40. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently modified their holdings of ASPN. Quest Partners LLC lifted its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after acquiring an additional 5,361 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $497,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Aspen Aerogels by 204.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company’s stock worth $14,106,000 after acquiring an additional 342,253 shares during the last quarter. Algert Global LLC lifted its stake in shares of Aspen Aerogels by 60.2% during the 3rd quarter. Algert Global LLC now owns 127,764 shares of the construction company’s stock worth $3,538,000 after acquiring an additional 48,007 shares during the last quarter. Finally, Penserra Capital Management LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $1,342,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.